| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |